DAVID MIZRO: Open Payments
NPI 1205882016 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 33 payments from 12 companies in 2025. Trend: 2023 $577 · 2024 $602 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $151 |
| Janssen Biotech, Inc. | 5 | $119 |
| UCB, Inc. | 3 | $72 |
| Amgen Inc. | 3 | $54 |
| Lilly USA, LLC | 2 | $46 |
| PFIZER INC. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: SKYRIZI, TREMFYA, Bimzelx, Otezla, ILUMYA, LITFULO, TALTZ, EBGLYSS.
Industry payments across NY — which companies pay providers there.
